Skip to main content
. 2026 Aug 27;13:1917271. doi: 10.3389/fmed.2026.1917271

Table 3.

Comparison of microbiological results.

Variables (positive) Total (n = 511) EOS group (n = 139) Non-EOS group (n = 372) P
Gram-positive bacteria, n(%) 51 (9.98) 13 (9.35) 38 (10.22) 0.772
Coagulase-negative staphylococci, n(%) 22 (4.31) 4 (2.88) 18 (4.84) 0.331
Streptococcus pneumoniae, n(%) 15 (2.93) 6 (4.32) 9 (2.42) 0.403
Enterococcus faecalis, n(%) 4 (0.78) 2 (1.44) 2 (0.54) 0.642
Staphylococcus aureus, n(%) 9 (1.76) 1 (0.72) 8 (2.15) 0.474
Viridans streptococci, n(%) 1 (0.20) 0 (0.00) 1 (0.27) 1.000
Streptococcus pyogenes, n(%) 1 (0.20) 1 (0.72) 0 (0.00) 0.272
Gram-negative bacteria, n(%) 100 (19.57) 21 (15.11) 79 (21.24) 0.120
Klebsiella species, n(%) 23 (4.50) 5 (3.60) 18 (4.84) 0.547
Pseudomonas aeruginosa, n(%) 27 (5.28) 6 (4.32) 21(5.65) 0.550
Stenotrophomonas maltophilia, n(%) 13 (2.54) 4 (2.88) 9(2.42) 0.757
Acinetobacter baumannii, n(%) 29 (5.68) 3 (2.16) 26(6.99) 0.036
Escherichia coli, n(%) 5 (0.98) 2 (1.44) 3(0.81) 0.888
Unidentified Gram-negative bacilli, n(%) 21 (4.11) 8 (5.76) 13(3.50) 0.252
Nocardia farcinica, n(%) 1 (0.20) 0 (0.0) 1(0.27) 1.000